AMA confronts the rise of nootropics

| 3 Min Read

Responding to the safety concerns generated by a growing personal use of nootropics, physicians at the Annual Meeting of the American Medical Association (AMA) today adopted new policy discouraging the nonmedical use of prescription drugs for cognitive enhancement in healthy individuals.

Nootropics – the so-called smart drugs – include a variety of prescription drugs, supplements, or other substances that claim to improve cognitive functions of healthy individuals, particularly executive function, memory, learning or intelligence.

Full press release available when you sign in

Sign in to the AMA website to get the full version of this press release. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Physician looks out a window

A 50% Medicare pay cut would put physician practices at risk

| 3 Min Read
Doctor works at a laptop

AI is moving fast. Health systems need guardrails.

| 9 Min Read
Hand holds U-shaped magnet

How to tell when physician retention gets more than lip service

| 6 Min Read
Two figures treat a giant eyeball

What doctors want patients to know about dry eyes

| 12 Min Read